Alkyl Amines Chemicals
Manufacturing · 1 quarter tracked · source-linked performance and management context.
Latest revenue
Pending
financial record pending verification
Quarters tracked
1
source records in the directory
Delivery assessment
Unscored
No scored management commitments are present yet.
Call date
2026-05-15
latest available source date
Signal trajectory
0 actual quartersCurrent read
Unscored
No scored management commitments are present yet.
Latest source read
What changed this quarter?
Alkyl Amines reported a flat year for FY26, with revenue and volume both declining ~1% YoY, impacted by weak demand and raw material disruptions. The company maintained market share but faced headwinds from Chinese dumping in acetonitrile, though anti-dumping duties began to help in Q4. Management guided for 5-10% volume growth in FY27, supported by pharma demand and improved pricing post-war. The new Kurum project is delayed to Q2 FY27. Margins are expected to improve from cyclical lows, but competition in methylamines from new entrant RCF and potential demand destruction from higher prices remain risks. The company is cautious on capex, with only ₹80-90 crore planned for FY27, mostly maintenance and completion of existing projects.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Watch
Revenue
Pending
Source date
2026-05-15
Across the record
Quarter history.
History modules